NCT05866276Completed
To Determine the Accuracy of SCreening for Occult REnal Disease (SCORED) Questionnaire for CKD Risk Among Asian Patients
A Real-World Multicentre Prospective Study to Determine the Accuracy of the SCORED (SCreening for Occult REnal Disease) Questionnaire for SCreening REnal Risk Early Against Nephropathy in Adult Population in Asia
Source: ClinicalTrials.gov · Last updated 12 May 2026
Brief summary (registry, in English)
To determine the accuracy of SCreening for Occult REnal Disease (SCORED) questionnaire for CKD risk among Asian Patients
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1426 (actual)
- First submitted
- 10 May 2023
- Start date
- 22 Jun 2023
- Primary completion date
- 31 May 2024
- Lead sponsor
- AstraZeneca
- Diseases
- Chronic kidney disease
- NCT number
- NCT05866276
What you commit to
- Study type: Observational
- Participants enrolled: 1426
- From 22 Jun 2023 to the primary completion date, 31 May 2024
- 3 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- \-
Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Perisai Husada Coordinator of this site? Confirm its status | Bandung | Indonesia | Unknown status |
| - Coordinator of this site? Confirm its status | Surabaya | Indonesia | Unknown status |
| Nguyen Tri Phuong Hospital Coordinator of this site? Confirm its status | Ho Chi Minh City | Vietnam | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.